Project Investigator Biography
Jamil Momand, Ph.D.
California State Univ.- Los Angeles
California State Univ., LA, Dept. of Chemistry and Biochemistry
511 State Univ., Dr. ,
Los Angeles, CA 90032
phone: (323) 343-2361
fax: (323) 343-6490
Dr. Jamil Momand is a Professor of Biochemistry at California State University Los Angeles (CSULA). Dr. Momand has a long standing interest in regulation of p53 tumor suppressor, which is inhibited in the vast majority of human cancers. In cancer cells, his laboratory discovered that p53 is susceptible to inhibition by oxidation of its cysteine thiol groups. Dr. Momand also directs two training programs – one is the Southern California Bioinformatics Summer Institute, offering didactic training and research opportunities for students interested in careers in bioinformatic.
The other training program is actually a partnership between CSULA and City of Hope, a National Cancer Institute-designated Comprehensive Cancer Center. The co-director at City of Hope (COH) is Susan Kane, a molecular biologist who specializes in chemotherapy drug resistance. This partnership, the CSULA-COH Cancer Collaborative, trains junior faculty and students for careers in cancer research. One aim of this Cancer Collaborative is to train undergraduates and graduates from underrepresented minority groups in cancer research. Minority students work on cancer research projects and have two advisors—one from CSULA and one from COH. Students get academic guidance and training from both advisors, with an overarching career objective of becoming cancer researchers—typically through earning an MD or PhD. The second arm of the Cancer Collaborative is to train junior faculty in health disparity research. Junior faculty from CSULA and COH join forces with senior faculty from COH to investigate the causes of cancer disparities.
The Cancer Collaborative has distributed funds to three ongoing projects: 1) “The Role of Cultural Health Beliefs and Health Behaviors Among Chinese, Korean, and Mexican American Breast Cancer Survivors,” 2) “ Understanding the Barriers and Facilitators to Adherence to Oral Chemotherapy in Hispanic Youth with Acute Lymphoblastic Leukemia,” and 3) “Prostate Cancer Outcomes by Race and Treatment Site.”View Partnership Abstract Description
Other Project Investigator
Susan Kane, Ph.D.